You are here

Exploring the Effects of Genomic Testing on Fear of Cancer Recurrence among Breast Cancer Survivors

Workflow State: 
Approved
Type of proposal: 
Participant recruitment (what is this?)
Does this project have funding?: 
Yes

Researcher Information

First name: 
Maurade
Last name: 
Gormley
Degree: 
MSN
Work phone number: 
(203) 767-6653

Institution Information

New York University Rory Meyers College of Nursing, NIH Funded Study
433 1st Avenue
10010 New York , NY
United States

Project Information

List of Collaborators: 
Gail Melkus, EdD, C-NP, Professor & Associate Dean for Research NYU Meyers College of Nursing gail.melkus@nyu.edu Dr. Melkus is the Florence and William Downs Professor in Nursing Research, Associate Dean for Research, and Director of the Muriel and Virginia Pless Center for Nursing Research. Her expertise in conducting behavioral intervention research and serving as a career development mentor to many rising early-career scientists will benefit Ms. Gormley in the conduct of the F31 study. She is a co-sponsor on the F31 grant. Bradley Aouizerat, PhD, Professor NYU College of Dentistry, Dept. of Oral and Maxillofacial Surgery bea4@nyu.edu Other Significant Contributor: Dr. Bradley Aouizerat is a Professor at the NYU College of Dentistry, where he serves as the Deputy Director of the Bluestone Center for Clinical Research. His research focuses on genetic and epigenetic determinants of symptoms in chronic disease, including pain, fatigue, sleep disturbances and depressive symptoms. He has extensive experience in cancer research, and among women with breast cancer, has published findings on women’s knowledge and understanding of sporadic breast cancer risk factors, genetic factors associated with sleep disturbance and morning fatigue, and trajectories of anxiety and depressive symptoms. He is the sponsor on the F31 grant and will contribute to the dissemination of study findings. Allison Vorderstrasse, D.N.Sc, MSN, RN, Associate Professor NYU Meyers College of Nursing av92@nyu.edu Dr. Vorderstrasse is an Associate Professor at the NYU Meyers College of Nursing and the Director of the Florence S. Downs PhD Program in Nursing Research and Theory. Her research experience examining the biobehavioral response to genetic testing for chronic disease is informative to the study. Marilyn Hammer, PhD, RN, Adjunct Associate Professor NYU Meyers College of Nursing and Director of Nursing Research, Mount Sinai Hospital Marilyn.hammer@mountsinai.org Dr. Hammer is Director of Research and Evidence-Based Practice at Mount Sinai Hospital and Adjunct Associate Professor at the NYU College of Nursing. Her research on inflammation, malglycemia, and cancer symptoms is informative for the study. Dr. Tish Knobf, PhD, RN, AOCN, FAAN Yale School of Nursing Professor of Nursing and Acute Care/Health Systems Division Chair Dr. Knobf’s clinical experience working with women with breast cancer extends over three decades. Her current research focuses on cancer survivorship, with a focus on the persistent and late effects of cancer treatment.
Number of Participants Needed: 
130
Inclusion and Exclusion Criteria: 
Inclusion Criteria In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Willingness and ability to participate in study assessments 2. Female 3. ≥ 18 years of age 4. Able to speak and read English 5. Stage I – IIIa hormone receptor-positive breast cancer 6. Oncotype Dx® results as part of their cancer treatment plan 7. At least six months since time of diagnosis and if applicable, post adjuvant chemotherapy 8. Less than 5 years since time of diagnosis 9. Currently prescribed endocrine therapy 10. Verbal consent Exclusion Criteria An individual who meets any of the following criteria will be excluded from participation in this study: 1. Current diagnosis of a major psychiatric illness (e.g., schizophrenia, bipolar disorder) 2. History of another primary cancer (e.g., lung, colon)

Project Details

Primary Area of Study: 
Budget Award Letter: 
Complete Grant Application (protocol if not grant-funded): 
IRB Approval: 
Yes